TSVT
Income statement / Annual
Last year (2024), 2seventy bio, Inc.'s total revenue was $37.86 M,
a decrease of 62.28% from the previous year.
In 2024, 2seventy bio, Inc.'s net income was -$57.25 M.
See 2seventy bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$37.86 M |
$100.39 M |
$91.50 M |
$54.52 M |
$248.12 M |
$44.30 M |
$54.58 M |
| Cost of Revenue |
$0.00
|
$16.92 M
|
$26.22 M
|
$12.59 M
|
$5.40 M
|
$2.98 M
|
$885,000.00
|
| Gross Profit |
$37.86 M
|
$83.47 M
|
$65.28 M
|
$41.93 M
|
$242.73 M
|
$41.32 M
|
$53.69 M
|
| Gross Profit Ratio |
1
|
0.83
|
0.71
|
0.77
|
0.98
|
0.93
|
0.98
|
| Research and Development Expenses |
$76.92 M
|
$230.76 M
|
$248.74 M
|
$261.94 M
|
$296.47 M
|
$297.65 M
|
$200.49 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$43.92 M
|
$69.41 M
|
$79.45 M
|
$93.51 M
|
$90.90 M
|
$81.65 M
|
$53.63 M
|
| Other Expenses |
$32.45 M
|
$20.91 M
|
$6.06 M
|
$21.65 M
|
$18.06 M
|
$20.13 M
|
$19.16 M
|
| Operating Expenses |
$153.29 M
|
$321.08 M
|
$328.19 M
|
$355.44 M
|
$387.36 M
|
$379.29 M
|
$254.12 M
|
| Cost And Expenses |
$153.29 M
|
$338.00 M
|
$354.40 M
|
$368.03 M
|
$392.76 M
|
$382.27 M
|
$255.01 M
|
| Interest Income |
$10.88 M
|
$12.41 M
|
$2.93 M
|
$88,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$15.49 M
|
| Depreciation & Amortization |
$7.10 M
|
$10.29 M
|
$11.53 M
|
$16.40 M
|
$13.19 M
|
$12.59 M
|
$13.35 M
|
| EBITDA |
-$98.45 M |
-$206.42 M |
-$251.38 M |
-$297.16 M |
-$131.45 M |
-$329.19 M |
-$187.08 M |
| EBITDA Ratio |
-2.6
|
-2.06
|
-2.75
|
-5.45
|
-0.53
|
-7.43
|
-3.43
|
| Operating Income Ratio |
-3.05
|
-2.37
|
-2.87
|
-5.75
|
-0.58
|
-7.63
|
-3.73
|
| Total Other Income/Expenses Net |
$58.18 M
|
$20.04 M
|
$8.76 M
|
$21.30 M
|
$24.52 M
|
$17.38 M
|
$3.68 M
|
| Income Before Tax |
-$57.25 M
|
-$217.57 M
|
-$254.15 M
|
-$292.21 M
|
-$120.11 M
|
-$320.59 M
|
-$199.75 M
|
| Income Before Tax Ratio |
-1.51
|
-2.17
|
-2.78
|
-5.36
|
-0.48
|
-7.24
|
-3.66
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$8,987.00
|
-$16.00 M
|
$18.06 M
|
$2.75 M
|
$19.16 M
|
| Net Income |
-$57.25 M
|
-$217.57 M
|
-$254.14 M
|
-$276.21 M
|
-$138.17 M
|
-$323.34 M
|
-$199.75 M
|
| Net Income Ratio |
-1.51
|
-2.17
|
-2.78
|
-5.07
|
-0.56
|
-7.3
|
-3.66
|
| EPS |
-1.1 |
-4.42 |
-7.13 |
-11.71 |
-5.93 |
-13.88 |
-8.58 |
| EPS Diluted |
-1.1 |
-4.42 |
-7.13 |
-11.71 |
-5.93 |
-13.88 |
-8.58 |
| Weighted Average Shares Out |
$52.22 M
|
$49.28 M
|
$35.64 M
|
$23.59 M
|
$23.29 M
|
$23.29 M
|
$23.29 M
|
| Weighted Average Shares Out Diluted |
$52.22 M
|
$49.28 M
|
$35.64 M
|
$23.59 M
|
$23.29 M
|
$23.29 M
|
$23.29 M
|
| Link |
|
|
|
|
|
|
|
